Morgan Stanley Lowers Its Investment Rating on Inktomi

Analyst concerned the Internet infrastructure software company could report lower than expected revenues based on performance of company peers

Morgan Stanley lowered its investment rating on Inktomi (INKT ) to neutral from outperform with Analyst Christopher Stix saying revenues for the Internet infrastructure software company could miss Wall Street's bar. The stock was off 4-3/4 at 13-3/4.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.